Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Farmabios
Gropello Cairoli, Pavia, Italyfarmabios.com ↗
- Ownership
- Private
- Employees
- ~93
- Development stage
- Other
01
Overview
Farmabios specializes in the development and manufacture of active pharmaceutical ingredients—especially steroids and high-potency substances—for global pharmaceutical companies. It offers both nonsterile and sterile APIs as well as custom synthesis services. The company has decades-long expertise in steroid chemistry and supports clients from process development through commercial supply. It was acquired by PharmaZell Group and merged into the new entity Axplora.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small moleculeSteroidsSemi-synthetic cephalosporinsHigh potent substancesAntibioticsPeptides
- Industry
- Contract Manufacturing Organization
02
Partnerships
Not specifically disclosed; works with global pharma companies as contract manufacturer/custom synthesis partner.
Beyond the preview
Go deeper on Farmabios.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Farmabios.